Home > Publications
2025
Thomas G. Davies, Monika Halicka, G.J. Melendez-Torres, Nicky J. Weltona; Deborah M. Caldwell
A methodological review of network meta-analyses applied to complex interventions for public health and a typology of the node-making process Journal Article
In: Journal of Clinical Epidemiology , 2025.
Links | Altmetric | Tags: Epidemiology
@article{Davies2025b,
title = {A methodological review of network meta-analyses applied to complex interventions for public health and a typology of the node-making process},
author = {Thomas G. Davies, Monika Halicka, G.J. Melendez-Torres, Nicky J. Weltona and Deborah M. Caldwell},
url = {https://www.jclinepi.com/article/S0895-4356(25)00189-1/fulltext},
doi = {https://doi.org/10.1016/j.jclinepi.2025.111856},
year = {2025},
date = {2025-09-25},
urldate = {2025-09-25},
journal = {Journal of Clinical Epidemiology },
keywords = {Epidemiology},
pubstate = {published},
tppubtype = {article}
}
2016
Olivia Remes, Carol Brayne, Rianne van der Linde; Louise Lafortune.
A systematic review of reviews on the prevalence of anxiety disorders in adult populations Journal Article
In: Brain and Behaviour, 2016.
Abstract | Links | Altmetric | Tags: Anxiety, Epidemiology, Mental Health
@article{,
title = {A systematic review of reviews on the prevalence of anxiety disorders in adult populations},
author = {Olivia Remes, Carol Brayne, Rianne van der Linde and Louise Lafortune.},
doi = {10.1002/brb3.497 },
year = {2016},
date = {2016-06-05},
journal = {Brain and Behaviour},
abstract = {Background
A fragmented research field exists on the prevalence of anxiety disorders. Here, we present the results of a systematic review of reviews on this topic. We included the highest quality studies to inform practice and policy on this issue.
Method
Using PRISMA methodology, extensive electronic and manual citation searches were performed to identify relevant reviews. Screening, data extraction, and quality assessment were undertaken by two reviewers. Inclusion criteria consisted of systematic reviews or meta‐analyses on the prevalence of anxiety disorders that fulfilled at least half of the AMSTAR quality criteria.
Results
We identified a total of 48 reviews and described the prevalence of anxiety across population subgroups and settings, as reported by these studies. Despite the high heterogeneity of prevalence estimates across primary studies, there was emerging and compelling evidence of substantial prevalence of anxiety disorders generally (3.8–25%), and particularly in women (5.2–8.7%); young adults (2.5–9.1%); people with chronic diseases (1.4–70%); and individuals from Euro/Anglo cultures (3.8–10.4%) versus individuals from Indo/Asian (2.8%), African (4.4%), Central/Eastern European (3.2%), North African/Middle Eastern (4.9%), and Ibero/Latin cultures (6.2%).
Conclusions
The prevalence of anxiety disorders is high in population subgroups across the globe. Recent research has expanded its focus to Asian countries, an increasingly greater number of physical and psychiatric conditions, and traumatic events associated with anxiety. Further research on illness trajectories and anxiety levels pre‐ and post‐treatment is needed. Few studies have been conducted in developing and under‐developed parts of the world and have little representation in the global literature.},
keywords = {Anxiety, Epidemiology, Mental Health},
pubstate = {published},
tppubtype = {article}
}
Background
A fragmented research field exists on the prevalence of anxiety disorders. Here, we present the results of a systematic review of reviews on this topic. We included the highest quality studies to inform practice and policy on this issue.
Method
Using PRISMA methodology, extensive electronic and manual citation searches were performed to identify relevant reviews. Screening, data extraction, and quality assessment were undertaken by two reviewers. Inclusion criteria consisted of systematic reviews or meta‐analyses on the prevalence of anxiety disorders that fulfilled at least half of the AMSTAR quality criteria.
Results
We identified a total of 48 reviews and described the prevalence of anxiety across population subgroups and settings, as reported by these studies. Despite the high heterogeneity of prevalence estimates across primary studies, there was emerging and compelling evidence of substantial prevalence of anxiety disorders generally (3.8–25%), and particularly in women (5.2–8.7%); young adults (2.5–9.1%); people with chronic diseases (1.4–70%); and individuals from Euro/Anglo cultures (3.8–10.4%) versus individuals from Indo/Asian (2.8%), African (4.4%), Central/Eastern European (3.2%), North African/Middle Eastern (4.9%), and Ibero/Latin cultures (6.2%).
Conclusions
The prevalence of anxiety disorders is high in population subgroups across the globe. Recent research has expanded its focus to Asian countries, an increasingly greater number of physical and psychiatric conditions, and traumatic events associated with anxiety. Further research on illness trajectories and anxiety levels pre‐ and post‐treatment is needed. Few studies have been conducted in developing and under‐developed parts of the world and have little representation in the global literature.
A fragmented research field exists on the prevalence of anxiety disorders. Here, we present the results of a systematic review of reviews on this topic. We included the highest quality studies to inform practice and policy on this issue.
Method
Using PRISMA methodology, extensive electronic and manual citation searches were performed to identify relevant reviews. Screening, data extraction, and quality assessment were undertaken by two reviewers. Inclusion criteria consisted of systematic reviews or meta‐analyses on the prevalence of anxiety disorders that fulfilled at least half of the AMSTAR quality criteria.
Results
We identified a total of 48 reviews and described the prevalence of anxiety across population subgroups and settings, as reported by these studies. Despite the high heterogeneity of prevalence estimates across primary studies, there was emerging and compelling evidence of substantial prevalence of anxiety disorders generally (3.8–25%), and particularly in women (5.2–8.7%); young adults (2.5–9.1%); people with chronic diseases (1.4–70%); and individuals from Euro/Anglo cultures (3.8–10.4%) versus individuals from Indo/Asian (2.8%), African (4.4%), Central/Eastern European (3.2%), North African/Middle Eastern (4.9%), and Ibero/Latin cultures (6.2%).
Conclusions
The prevalence of anxiety disorders is high in population subgroups across the globe. Recent research has expanded its focus to Asian countries, an increasingly greater number of physical and psychiatric conditions, and traumatic events associated with anxiety. Further research on illness trajectories and anxiety levels pre‐ and post‐treatment is needed. Few studies have been conducted in developing and under‐developed parts of the world and have little representation in the global literature.